[Haemoglobin levels during prolonged treatment with isoprodian, a combination of isoniazid, prothionamide and diaphenylsulphone (author's transl)].
D000368:Aged; D003622:Dapsone / Q000494:pharmacology*; D004338:Drug Combinations; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D007539:Isonicotinic Acids / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011515:Prothionamide / Q000494:pharmacology*
D004338:Drug Combinations; D007539:Isonicotinic Acids; D011515:Prothionamide; D003622:Dapsone; D007538:Isoniazid
Verhalten des Hämoglobins unter Langzeitbehandlung mit Isoniazid + Prothionamid + Diaphenylsulfon (Isoprodian)